RxDoctor Payments Data

Zara Patel, MD

Otolaryngology · Stanford, CANPI 1487814109

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (49.8%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Medtronic accounts for 67.8% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2023 at $33,643 and has fallen 93.6% since, to $2,167 in 2025. Among otolaryngology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$128,009in general payments, 2019–2025

Across 128 payments — averaging $1000.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$87K
  • Stryker$18K
  • Optinose US, Inc.$8K
  • Regeneron$7K
  • Sanofi$4K
  • Johnson & Johnson$2K
  • plus $937 from 5 others
$18,828in research payments, 2019–2025

Across 6 payments — averaging $3137.94 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Optinose US, Inc.$17K
  • Regeneron$867
  • Sanofi$750

What the payments were for

  • Consulting fees$52,23041%
  • Speaking & faculty fees$63,70650%
  • Travel & lodging$8,0556%
  • Food & beverage$4,0183%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)86$86,830
Stryker16$18,491
Optinose US, Inc.10$7,716
Regeneron3$7,305
Sanofi1$4,250
Johnson & Johnson1$2,480
Intersect ENT, Inc.2$345
Integra Lifesciences Corporation3$288
GSK4$236
Covidien LP1$48
Boston Scientific1$21

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$128,009 in reported general payments places this provider in the 95th percentile of 1,021 otolaryngology providers in California.

See all otolaryngology providers in California

Medicare billing

Part B allowed, 2024
$98,788
Medicare patients
175
Services billed
519

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Azelastine Hcl13$240

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Stanford

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →